|
108
|
Safety Signal of Ivermectin and the Risk of Encephalopathy
|
|
Signal
|
|
|
107
|
Safety Signal of Finasteride and the Risk of Diabetes Mellitus
|
|
Signal
|
|
|
106
|
Safety Signal of Atezolizumab and the Risk of Keratitis
|
|
Signal
|
|
|
105
|
Safety Signal of Bevacizumab and the Risk of Fournier’s gangrene
|
|
Signal
|
|
|
104
|
Safety Signal of Colchicine and the Risk of Pneumonia
|
|
Signal
|
|
|
102
|
Safety Signal of Tioguanine and the Risk of Nausea
|
|
Signal
|
|
|
101
|
Safety Signal of Nivolumab and the Risk of Cystitis
|
|
Signal
|
|
|
100
|
Safety Signal of Infliximab and the Risk of Bursitis
|
|
Signal
|
|
|
99
|
Safety Signal of Cefuroxime and the Risk of Kounis Syndrome
|
|
Signal
|
|
|
98
|
Safety Signal of Azithromycin and the Risk of Mitral valve incompetence
|
|
Signal
|
|
